Some studies suggest that SIRT4 functions as a tumor suppressor by activating the pathways associated with cell cycle regulation and apoptosis, such as the phosphorylation of p53, positioning it as a potential target for therapeutic intervention [106,107]. This evidence concerns the gene TP53 and neoplasm.